Design Therapeutics Stock Momentum Indicators Average Directional Movement Index

DSGN Stock  USD 5.57  0.09  1.64%   
Design Therapeutics momentum indicators tool provides the execution environment for running the Average Directional Movement Index indicator and other technical functions against Design Therapeutics. Design Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Average Directional Movement Index indicator function is designed to identify and follow existing trends. Momentum indicators of Design Therapeutics are pattern recognition functions that provide distinct formation on Design Therapeutics potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was fourty-seven with a total number of output elements of fourteen. The average directional index (ADX) measures the strength of a prevailing trend of Design Therapeutics and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Design Therapeutics ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator

Design Therapeutics Technical Analysis Modules

Most technical analysis of Design Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Design from various momentum indicators to cycle indicators. When you analyze Design charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Design Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Design Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Design Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Design Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Design Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Design Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Design Therapeutics, we also check how macroeconomic factors affect Design Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Graham Number11.546.01
Receivables Turnover0.02030.0181
Hype
Prediction
LowEstimatedHigh
0.285.5511.37
Details
Intrinsic
Valuation
LowRealHigh
1.947.7613.58
Details
Naive
Forecast
LowNextHigh
0.105.2211.04
Details
3 Analysts
Consensus
LowTargetHigh
13.8815.2516.93
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Design Therapeutics. Your research has to be compared to or analyzed against Design Therapeutics' peers to derive any actionable benefits. When done correctly, Design Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Design Therapeutics.

Align your values with your investing style

In addition to having Design Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Power Assets Idea
Power Assets
Invested over 200 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Business Services Idea
Business Services
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Tech Growth Idea
Tech Growth
Invested few shares
Military Industrial Idea
Military Industrial
Sold few shares
Momentum Idea
Momentum
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
FinTech Idea
FinTech
Invested over 40 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
When determining whether Design Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Design Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Design Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Design Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.85)
Revenue Per Share
0.001
Return On Assets
(0.14)
Return On Equity
(0.18)
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.